Location: Home
  • search
  • go
  • Relate News
  • 4/20/2017Generic Consistency Evaluation in China: The Coming Paradigm Shift In ...
  • 4/19/2017Merck Group to Expand Online Business 'Dramatically' in China
  • 4/19/2017R&D Spending of Top Domestically-Listed Pharmaceutical Companies i...
  • 4/19/2017The Pulse of China's Healthcare
  • 4/18/2017Celgene Licenses East Asian Right of TORC1/2 inhibitor CC-223 to Anten...
  • 4/18/2017Traditional Chinese Medicine? 100% Made In Japan
  • 4/18/2017Staffing for China's Rapidly Growing Biomanufacturing Industry
  • 4/18/2017Novartis CEO Anticipates Accelerated Chinese Pharma Growth
  • 4/18/2017MOHRSS Seeks Suggestions on Dynamic Revision Mechanism of BMI Drug Rei...
  • 4/17/2017PhRMA Criticizes China Over Failure to Uphold Data Exclusivity
  • 4/17/2017HitGen, Pfizer Enter Partnership to Build Novel DELs
  • 4/15/2017MOHRSS Issues Notice on Proposed Drugs for Reimbursement Subject to Ne...
  • 4/15/2017Recent Executive Moves
  • 4/15/2017NDRC Plans to Remove Hospital Drug Sales Margins in All Public Hospita...
  • 4/13/2017CDE Solicits Public Comments on Six TCM Technical Guidelines
  • 4/13/2017CFDA Issues New Announcement (2017#42) for Clinical Data Self-Inspecti...
  • 4/13/2017State Council Pushes Forward Infrastructural Building of Medical Conso...
  • 4/12/2017Summary of Drug Registration Evaluation and Approval in the Past Five ...
  • 4/12/2017Top TCs and Drug Suppliers to Chinese Hospitals 2016
  • 4/11/2017China to Introduce Interpretations for Application of Criminal Laws fo...
  • 4/11/2017Shenzhen Makes Corrections after NDRC Finds the City's GPO Reform in V...
  • 4/11/2017CBMG and GE Healthcare Announce Partnership to Establish Joint Lab to ...
  • 4/11/2017IBM and Hejia Launch Supply Chain Financial Services Platform for Phar...
  • 4/7/2017MSD Renews Distribution Agreement with Zhifei for Two Vaccines
  • 4/6/2017CBMG Expands cGMP Biologic Manufacturing Facility in Wuxi
  • 4/6/2017Recent Executive Moves
  • 4/6/2017NHFPC, CFDA Issue Joint Notice to Strengthen Filing and Regulation of ...
  • 4/6/2017CFDA Approves JHL's IND for Clinical Trial of Rituximab Biosimilar
  • 4/5/2017USFDA Warns Lumis Global Pharma of cGMP Deficiencies
  • 4/5/2017Listed Chinese Pharma Cos Maintains Growth in 2016
  • Page:163/334 Total number of articles:10002: [First][<<] [161] [162] [163] [164] [165] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group